AQR Arbitrage’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

AQR Arbitrage’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-482,993	Closed	-$5.23M	–	843
2023 Q3	$5.23M	Hold	482,993	–	–	0.24%	103
2023 Q2	$5.14M	Sell	482,993 -111,765	-19%	-$1.18M	0.22%	115
2023 Q1	$6.21M	Sell	594,758 -29,196	-5%	-$302K	0.19%	150
2022 Q4	$6.41M	Hold	623,954	–	–	0.16%	178
2022 Q3	$6.25M	Hold	623,954	–	–	0.14%	198
2022 Q2	$6.27M	Hold	623,954	–	–	0.14%	197
2022 Q1	$6.17M	Buy	+623,954	New	+$6.16M	0.16%	156

AQR Arbitrage's BIOS Position: Q4 2023 in Review

AQR Arbitrage sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 482,993 shares — an estimated $5.23M sold.

AQR Arbitrage first reported a position in BIOS in Q1 2022 and held it in 7 quarters. The position peaked at $6.41M in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

AQR Arbitrage reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
AQR Arbitrage sold 482,993 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $5.23M.
AQR Arbitrage first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 7 quarters.
AQR Arbitrage's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $6.41M in Q4 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on AQR Arbitrage's 13F filing for Q4 2023, filed 14 Feb 2024.